4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-23-000086
President & CEO gave up 2,205 shares (to pay taxes)
- President & CEO acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hirsch Andrew · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-30 | Exercise or conversion : show line 1 in the form | +7,500 | 116,106 | D | ||
| 2023-08-30 | Shares withheld for taxes : show line 2 in the form | −2,205 | $2.93 | $6,461 | 113,901 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-30 | Exercise or conversion : show line 3 in the form Performance Restricted Stock Units | −7,500 | 55,000 | D |
Loading xslF345X05/wk-form4_1693512793.xml…